Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-10-14

FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for insulin lispro from Eli Lilly, along with a diluent, updating or clarifying the labeling for use in diabetes managem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DILUENT (diluents)
  • Humalog (insulin lispro)

Snippet

SUPPL AP for INSULIN LISPRO (INSULIN LISPRO)